Publication | Open Access
Effects of liraglutide on gastrointestinal functions and weight in obesity: A randomized clinical and pharmacogenomic trial
110
Citations
41
References
2022
Year
Liraglutide, 3 mg, induces weight loss with delay in GES T<sub>1/2</sub> and reduces calorie intake. Slowing GES and variations in GLP1R and TCF7L2 are associated with liraglutide effects in obesity.
| Year | Citations | |
|---|---|---|
Page 1
Page 1